KEAP1 and gestational diabetes: In conclusion, the present study demonstrated that inhibiting PGK1 has protective effects on GDM placenta and pregnancy outcomes by increasing estradiol levels, promoting Keap1 dimerization, activating the Nrf2-ARE pathway, restoring mitochondrial function, and ultimately mitigating OS in GDM placenta.